Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 6424 matches for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

New studies reveal optimal time intervals for COVID-19 vaccine boosters

Two new papers from scientists in the Nuffield Department of Medicine and other University of Oxford institutions have shown how the immune system reacts differently depending on the length of interval between vaccine doses.

The Kaiya Foundation to fund leukaemia research at University of Oxford

The Kaiya Foundation has awarded one of its first major research grants, which will fund pioneering research into the fundamental cause of a high-risk leukaemia. The grant is being made to Dr Emily Neil and Professor Anindita Roy from the Childhood Leukaemia Research Group, based at the University of Oxford, in the hope that their discoveries will transform treatment approaches for sufferers through personalised medicine.

Teenage period pain linked to higher risk of chronic pain in adulthood

Teenagers who experience moderate or severe period pain are significantly more likely to develop chronic pain in adulthood – including pain beyond the pelvis – according to a major new study from the University of Oxford, funded by the Medical Research Foundation.

Oxford-led team awarded significant grant to improve kidney transplant decision-making with AI

Researchers from the Centre for Evidence in Transplantation (CET), led by Associate Professor Simon Knight, have been awarded a prestigious five-year National Institute for Health Research (NIHR) Programme Grant for Applied Research (PGfAR). The project will develop and evaluate AI-driven clinical decision support tools to help clinicians make better-informed choices about kidney transplant offers.

Weight loss alone doesn’t ease atrial fibrillation symptoms in older adults, study finds

A clinical trial led by researchers in the University of Oxford’s Radcliffe Department of Medicine and Oxford Population Health, has found that while a structured weight-loss programme helped older adults with atrial fibrillation (AF) shed weight safely and sustainably, it did not improve their heart rhythm symptoms or reduce the need for further treatment.

Home-based heart rhythm screening improves diagnosis of common heart condition

A wearable electrocardiogram (ECG) patch increases diagnosis of a common heart rhythm disorder, according to a study by researchers from Nuffield Department of Primary Care Health Sciences and led by a team at Oxford Population Health.

Surgery to treat chronic sinus disease more effective than antibiotics

Sinus surgery is more effective than antibiotics at treating chronic rhinosinusitis, according to a major clinical trial led by UCL, coordinated by the Oxford Clinical Trials Research Unit (OCTRU) and Surgical Intervention Trials Unit (SITU) at NDORMS, in collaboration with researchers across the UK.

New research shows that pressure flips the switch on cancer cells

A new study published in Nature reveals that the mechanical environment surrounding a tumour can cause cancer cells to change their behaviour, triggering a switch from rapid growth to a more invasive, drug-resistant state.

Exceptional Oxford researchers awarded first Royal Society Faraday Discovery Fellowships

Three pioneering Oxford researchers are among the first recipients of the Royal Society Faraday Discovery Fellowships, prestigious long-term awards to support exceptional mid-career research leaders in the UK. Only seven academics were selected in total from more than 600 initial applications.

Brain’s functional networks operate in cycles, study finds

The brain’s networks activate in structured cycles, according to a major new study led by the Department of Psychiatry at the University of Oxford.

Four Oxford researchers recognised in the 2025 Royal Society Awards

The annual Royal Society Awards recognise exceptional research achievements through a series of prestigious medals and prizes. Of the 27 awards for 2024-25, announced today, four honour Oxford University researchers for their outstanding contributions to scientific discovery, public engagement and research culture.

Oxford University spinout OrganOx to be acquired by Terumo for a record $1.5bn

An agreement has been reached for the acquisition of OrganOx, a pioneering University of Oxford spinout transforming kidney and liver transplantation, by Terumo Corporation, a global medical technology company headquartered in Tokyo, Japan, for US$1.5 billion. The transaction, which is subject to regulatory and other approvals, would be the largest acquisition of an Oxford University spinout to date, and one of the most significant venture capital exits in UK university spinout history.

Planning application submitted for a major mental health and medical research campus in Oxford

Plans to transform an NHS site into a major mental health and medical research campus in Headington have been submitted to Oxford City Council by Oxford Health NHS Foundation Trust.

Oxford researchers develop uniquely shaped microstent to combat glaucoma

A team of researchers at the University of Oxford have unveiled a pioneering ‘microstent’ which could revolutionise treatment for glaucoma, a common but debilitating condition. The study has been published in The Innovation, Cell Press.

Chronic pain research breakthrough identifies promising drug target

For the first time, a team of researchers have identified a new genetic link to pain, offering a promising drug target to alleviate chronic pain.

Using AI to reclassify multiple sclerosis progression

Researchers in the Big Data Institute at the University of Oxford, together with MS experts from ten leading institutions across the world and drug developers from Novartis and Roche, have collaborated to develop an artificial intelligence (AI) model for reclassifying the progression of multiple sclerosis (MS). This model is based on the largest collection of clinical trial data (Novartis-Oxford MS dataset) from people living with MS.

Scientists reveal how new diabetes and obesity drugs work

A team led by scientists at the University of Oxford and the Leibniz-Forschungsinstitut für Molekulare Pharmakologie in Berlin has used fluorescent versions of next-generation diabetes and obesity drugs to reveal, for the first time, exactly which cells they target in the pancreas and brain.

Study finds giving pregnant women cash transfers cuts infant mortality in half

A new study by Associate Professor Dennis Egger (Department of Economics and Centre for the Study of African Economies, University of Oxford) and researchers at the University of California, Berkeley reveals that giving unconditional cash transfers to pregnant women in rural Kenya significantly reduces infant and child mortality.

First volunteers receive Rift Valley fever vaccine in Kenya Phase II trial

On 8 July 2025, researchers at the KEMRI-Wellcome Trust Research Programme began the Phase II trial of the ChAdOx1 RVF vaccine in Kilifi, Kenya—the most advanced Rift Valley fever vaccine study in an outbreak-prone region. Led by Oxford University and funded by CEPI, this milestone brings us closer to a licensed vaccine for protecting lives and livelihoods.

Platelets Shown to Store DNA in Study that could Transform Cancer Screening

Study led by Psaila Group uncovers previously unknown function of platelets as DNA ‘vacuum cleaners’ in the blood, with profound implications for cancer diagnosis and prenatal screening.

Load More